Publications:  Dr Irene Rodriguez-Hernandez

Georgouli M, Herraiz C, Crosas-Molist E, Fanshawe B, Maiques O, Perdrix A, Pandya P, Rodriguez-Hernandez I et al.(2019). Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment. Cell vol. 176, (4) 757-774.e23.

Maiques O, Barceló C, Panosa A, Pijuan J, Orgaz JL, Rodriguez-Hernandez I, Matas-Nadal C, Tell G et al.(2018). T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1. Pigment Cell Melanoma Res vol. 31, (4) 484-495.

Krupina K, Kleiss C, Awal S, Rodriguez-Hernandez I, Sanz-Moreno V, Sumara I(2018). UBASH3B-mediated silencing of the mitotic checkpoint: Therapeutic perspectives in cancer. Mol Cell Oncol vol. 5, (2)

Crosas-Molist E, Bertran E, Rodriguez-Hernandez I, Herraiz C, Cantelli G, Fabra À, Sanz-Moreno V, Fabregat I(2017). The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination. Oncogene vol. 36, (21) 3002-3014.

Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Gonzalez-Buendia L, Delgado-Tirado S, López JC, González-Sarmiento R, Pastor JC(2017). Functional characterization of rs2229094 (T>C) polymorphism in the tumor necrosis factor locus and lymphotoxin alpha expression in human retina: the Retina 4 project. Clin Ophthalmol vol. 11, 973-981.

Saul L, Ilieva KM, Bax HJ, Karagiannis P, Correa I, Rodriguez-Hernandez I, Josephs DH, Tosi I et al.(2016). IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin. Sci Rep vol. 6,

Herraiz C, Calvo F, Pandya P, Cantelli G, Rodriguez-Hernandez I, Orgaz JL, Kang N, Chu T et al.(2016). Reactivation of p53 by a Cytoskeletal Sensor to Control the Balance Between DNA Damage and Tumor Dissemination. J Natl Cancer Inst vol. 108, (1)

Rodriguez-Hernandez I, Cantelli G, Bruce F, Sanz-Moreno V(2016). Rho, ROCK and actomyosin contractility in metastasis as drug targets. F1000Res vol. 5,

Cantelli G, Orgaz JL, Rodriguez-Hernandez I, Karagiannis P, Maiques O, Matias-Guiu X, Nestle FO, Marti RM et al.(2015). TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination. Curr Biol vol. 25, (22) 2899-2914.

Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutierrez M-T, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon YD et al.(2015). BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project. Acta Ophthalmol vol. 93, (7) e541-e549.

Rodriguez-Hernandez I, Perdomo S, Santos-Briz A, Garcia JL, Gomez-Moreta JA, Cruz JJ, Gonzalez-Sarmiento R(2014). Analysis of DNA repair gene polymorphisms in glioblastoma. Gene vol. 536, (1) 79-83.

Rodríguez-Hernández I, Vázquez-Cedeira M, Santos-Briz A, García JL, Fernández IF, Gómez-Moreta JA, Martin-Vallejo J, González-Sarmiento R et al.(2013). VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis. BMC Clin Pathol vol. 13, (1)

Pastor-Idoate S, Rodriguez-Hernández I, Rojas J, Fernández I, García-Gutierrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon Y et al.(2013). The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project. Ophthalmology vol. 120, (3) 623-628.

Rodríguez-Hernández I, Garcia JL, Santos-Briz A, Hernández-Laín A, González-Valero JM, Gómez-Moreta JA, Toldos-González O, Cruz JJ et al.(2013). Integrated analysis of mismatch repair system in malignant astrocytomas. PLoS One vol. 8, (9)

Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutiérrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon Y et al.(2013). The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy. PLoS One vol. 8, (12)

Gomez-Sanchez JC, Delgado-Esteban M, Rodriguez-Hernandez I, Sobrino T, Perez de la Ossa N, Reverte S, Bolaños JP, Gonzalez-Sarmiento R et al.(2011). The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke. J Exp Med vol. 208, (3) 429-437.